76 results
8-K
EX-10.1
TFFP
Tff Pharmaceuticals Inc
2 May 24
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
5:10pm
(or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto … of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise
8-K
TFFP
Tff Pharmaceuticals Inc
29 Apr 24
Regulation FD Disclosure
6:06am
The following exhibit is furnished with this report:
Exhibit 99.1
The Company’s presentation materials
Filed Electronically herewith
Cover Page
DEFA14A
TFFP
Tff Pharmaceuticals Inc
22 Apr 24
Additional proxy soliciting materials
4:20pm
Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials … , if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials:
Fee
D
e9hw9yx26d2vdl
2 Apr 24
$1.18 mm in options / securities to be acquired, 2 investors
4:30pm
8-K
EX-99.1
x03te56
28 Mar 24
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
nh0c5tsryz s1r7
27 Mar 24
Regulation FD Disclosure
4:01pm
8-K
EX-99.1
uzn4p6rfbprtg
27 Mar 24
Regulation FD Disclosure
4:01pm
8-K
EX-10.1
lbmy9jbfmranomkq3i
22 Mar 24
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:25pm
8-K
EX-99.1
nu3iib d0k
19 Dec 23
TFF Pharmaceuticals Announces Reverse Stock Split
6:07am
8-K
EX-99.3
gd97rodb9eq9w
19 Dec 23
TFF Pharmaceuticals Announces Reverse Stock Split
6:07am
8-K
EX-99.1
sld7svdhs1s
15 Dec 23
TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors
4:06pm
8-K
EX-99.2
2yzrs pn947dkq27z
4 Dec 23
TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
5:26pm
8-K
EX-99.1
h3y9yc6 gs2i
4 Dec 23
TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
5:26pm
8-K
EX-99.1
s8kzgivg wv0
14 Nov 23
TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results
4:06pm
DEFA14A
hh8ufxf1
4 Oct 23
Additional proxy soliciting materials
4:07pm